NCT03253796 – Golimumab Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) Posted on October 14, 2024 by Jessica Ritchie -
NCT02186873 – A Study of Golimumab in Participants With Active Ankylosing Spondylitis Posted on August 5, 2023 by tsuperadmin -
NCT02846545 – SIMPONI® to Arrest β-cell Loss in Type 1 Diabetes Posted on August 5, 2023 by tsuperadmin -
NCT01453725 – A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects With Active Axial Spondyloarthritis (Also Known as MK-8259-006-02) Posted on October 23, 2018 by tsuperadmin -
NCT00207740 – A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study Evaluating the Efficacy and Safety of CNTO 148 Administered Subcutaneously in Symptomatic Subjects With Severe Persistent Asthma Posted on August 6, 2018 by tsuperadmin -
NCT01962974 – A Golimumab Phase 3b, Multicenter, Assessment of Intravenous Efficacy in Rheumatoid Arthritis Subjects Who Have Diminished Disease Control Despite Treatment With Infliximab (REMICADE®) Posted on August 6, 2018 by tsuperadmin -
NCT01988961 – A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis Posted on August 6, 2018 by tsuperadmin -
NCT01863771 – A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis Posted on August 6, 2018 by tsuperadmin -
NCT01004432 – Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA) Posted on August 6, 2018 by tsuperadmin -
NCT02181673 – A Study of Golimumab in Participants With Active Psoriatic Arthritis Posted on August 6, 2018 by tsuperadmin -